Urological involvement in renal transplantation

International Journal of Urology

Volumn 18, Issue 3, 2011, Pages 185-193

  Sackett, Daniel D ^a   Singh, Pooja ^b   Lallas, Costas D ^a  

^a Department of Urology ^*  (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Renal transplantation; Urological complication; Urological surgery

Indexed keywords

BCG VACCINE; PROSTATE SPECIFIC ANTIGEN;

BCG VACCINATION; BLADDER CANCER; BLADDER CARCINOMA; BLADDER DYSFUNCTION; CANCER RISK; CARCINOMA IN SITU; DONOR SELECTION; ELECTROCARDIOGRAPHY; ENTERITIS; GLEASON SCORE; GRAFT RECIPIENT; HEMATURIA; HISTOCOMPATIBILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HYDRONEPHROSIS; HYPERCALCEMIA; HYPEROXALURIA; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; KIDNEY CALCIFICATION; KIDNEY CANCER; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ACIDOSIS; LIVING DONOR; MAMMOGRAPHY; MEDICAL HISTORY; MICTURITION CYSTOURETHROGRAPHY; NEPHRECTOMY; NEPHROLITHIASIS; NEPHROSTOMY; ORCHIECTOMY; ORGAN DONOR; PELVIS LYMPHADENECTOMY; PENIS CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; RISK BENEFIT ANALYSIS; SARCOIDOSIS; SEROLOGY; TESTIS CANCER; TRANSITIONAL CELL CARCINOMA; ULTRASOUND; URETER STONE; URETER STRICTURE; URETHRA STRICTURE; URINARY DIVERSION; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION; UROGENITAL TRACT CANCER; UROGENITAL TRACT DISEASE; UROLOGY; X RAY;

GENERAL SURGERY; HUMANS; KIDNEY TRANSPLANTATION; PATIENT CARE TEAM; POSTOPERATIVE COMPLICATIONS; UROLOGY;

EID: 79951796007     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02707.x     Document Type: Review

References (63)

1. Harrison JH, Merrill JP, Murray JE. Renal homotransplantation in identical twins. Surg. Forum 1956; 6: 432-6.
2. Power RE, Hickey DP, Little DM. Urological evaluation prior to renal transplantation. Transplant. Proc. 2004; 36: 2962-7.
3. Bethesda MD NIoH. National Institute of Diabetes and Digestive and Kidney Diseases 2009. US Renal Data System: USRDS 2009 Annual Data Report. 2009.
4. Flechner SM, Novick AC. The current level of involvement of urological trainees and faculty in clinical kidney transplantation in the United States and Canada. J. Urol. 1997; 157: 1223-5.
5. Wafa EW, Donia AF, Ali-El-Dein B etal. Evaluation and selection of potential live kidney donors. J. Urol. 2004; 171: 1424-7.
6. Fuller TF, Liefeldt L, Dragun D, Tullmann M, Loening SA, Giessing M. [Urological evaluation and follow-up of the kidney transplant patient]. Urologe A 2006; 45: 53-9.
7. Giessing M, Kroencke TJ, Taupitz M etal. Gadolinium-enhanced three-dimensional magnetic resonance angiography versus conventional digital subtraction angiography: which modality is superior in evaluating living kidney donors? Transplantation 2003; 76: 1000-2.
8. Davis CL, Delmonico FL. Living-donor kidney transplantation: a review of the current practices for the live donor. J. Am. Soc. Nephrol. 2005; 16: 2098-110.
9. Ennis J, Kocherginsky M, Schumm LP, Worcester E, Coe FL, Josephson MA. Trends in kidney donation among kidney stone formers: a survey of US transplant centers. Am. J. Nephrol. 2009; 30: 12-18.
10. Delmonico F. A report of the Amsterdam forum on the care of the live kidney donor: data and medical guidelines. Transplantation 2005; 79: S53-66.
11. Rashid MG, Konnak JW, Wolf JS Jr etal. Ex vivo ureteroscopic treatment of calculi in donor kidneys at renal transplantation. J. Urol. 2004; 171: 58-60.
12. Penn I. Malignancy transmitted from the organ donor. Graft. 1998; 1 (2 Suppl I): 19-20.
13. Buell JF, Beebe TM, Trofe J etal. Donor transmitted malignancies. Ann. Transplant. 2004; 9: 53-6.
14. Buell JF, Hanaway MJ, Thomas M etal. Donor kidneys with small renal cell cancers: can they be transplanted? Transplant. Proc. 2005; 37: 581-2.
15. D'Errico-Grigioni A, Fiorentino M, Vasuri F etal. Expanding the criteria of organ procurement from donors with prostate cancer: the application of the new Italian guidelines. Am. J. Transplant. 2010; 10: 1907-11.
16. Breda A, Veale J, Liao J etal. Complications of laparoscopic living donor nephrectomy and their management: the UCLA experience. Urology 2007; 69: 49-52.
17. Sundaram CP, Martin GL, Guise A etal. Complications after a 5-year experience with laparoscopic donor nephrectomy: the Indiana University experience. Surg. Endosc. 2007; 21: 724-8.
18. Jacobs SC, Cho E, Foster C etal. Laparoscopic donor nephrectomy: the University of Maryland 6-year experience. J. Urol. 2004; 171: 47-51.
19. Su LM, Ratner LE, Montgomery RA etal. Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following 381 consecutive cases. Ann. Surg. 2004; 240: 358-63.
20. Ko EY, Castle EP, Desai PJ etal. Utility of the endovascular stapler for right-sided laparoscopic donor nephrectomy: a 7-year experience at Mayo Clinic. J. Am. Coll. Surg. 2008; 207: 896-903.
21. Chin EH, Hazzan D, Edye M etal. The first decade of a laparoscopic donor nephrectomy program: effect of surgeon and institution experience with 512 cases from 1996 to 2006. J. Am. Coll. Surg. 2009; 209: 106-13.
22. Fisher PC, Montgomery JS, Johnston WK III etal. 200 consecutive hand assisted laparoscopic donor nephrectomies: evolution of operative technique and outcomes. J. Urol. 2006; 175: 1439-43.
23. Posselt AM, Mahanty H, Kang SM etal. Laparoscopic right donor nephrectomy: a large single-center experience. Transplantation 2004; 78: 1665-9.
24. Abrahams HM, Freise CE, Kang SM, Stoller ML, Meng MV. Technique, indications and outcomes of pure laparoscopic right donor nephrectomy. J. Urol. 2004; 171: 1793-6.
25. Disick GI, Shapiro ME, Miles RA, Munver R. Critical analysis of laparoscopic donor nephrectomy in the setting of complex renal vasculature: initial experience and intermediate outcomes. J. Endourol. 2009; 23: 451-5.
26. Barry JM. Current status of renal transplantation. Patient evaluations and outcomes. Urol. Clin. North Am. 2001; 28: 677-86.
27. Cairns HS, Leaker B, Woodhouse CR, Rudge CJ, Neild GH. Renal transplantation into abnormal lower urinary tract. Lancet 1991; 338: 1376-9.
28. Shandera KC, Rozanski TA, Jaffers G. The necessity of voiding cystourethrogram in the pretransplant urologic evaluation. Urology 1996; 47: 198-200.
29. Power RE, O'Malley KJ, Khan MS, Murphy DM, Hickey DP. Renal transplantation in patients with an augmentation cystoplasty. BJU Int. 2000; 86: 28-31.
30. Kalble T, Lucan M, Nicita G, Sells R, Burgos Revilla FJ, Wiesel M. EAU guidelines on renal transplantation. Eur. Urol. 2005; 47: 156-66.
31. Paolone DR. Benign prostatic hyperplasia. Clin. Geriatr. Med. 2010; 26: 223-39.
32. Vedrine N, Nsabimbona B, Soares P, Deteix P, Boiteux JP, Guy L. [Transurethral resection or incision of the prostate in the immediate postoperative follow-up of renal transplantation]. Prog. Urol. 2009; 19: 845-9.
33. Odorico JS, Knechtle SJ, Rayhill SC etal. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996; 61: 228-34.
34. Lee DI, Clayman RV. Hand-assisted laparoscopic nephrectomy in autosomal dominant polycystic kidney disease. J. Endourol. 2004; 18: 379-82.
35. Kramer A, Sausville J, Haririan A, Bartlett S, Cooper M, Phelan M. Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience. J. Urol. 2009; 181: 724-8.
36. Bremmer MS, Jacobs SC. Renal artery embolization for the symptomatic treatment of adult polycystic kidney disease. Nat. Clin. Pract. Nephrol. 2008; 4: 236-7.
37. Maisonneuve P, Agodoa L, Gellert R etal. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-9.
38. Stewart JH, Buccianti G, Agodoa L etal. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J. Am. Soc. Nephrol. 2003; 14: 197-207.
39. Farivar-Mohseni H, Perlmutter AE, Wilson S, Shingleton WB, Bigler SA, Fowler JE Jr. Renal cell carcinoma and end stage renal disease. J. Urol. 2006; 175: 2018-20; discussion 2021.
40. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J. Urol. 2001; 166: 63-7.
41. Penn I. Evaluation of transplant candidates with pre-existing malignancies. Ann. Transplant. 1997; 2: 14-17.
42. Girndt M, Kohler H. Waiting time for patients with history of malignant disease before listing for organ transplantation. Transplantation 2005; 80: S167-70.
43. Gifford RR, Wofford JE, Edwards WG Jr. Carcinoma of the bladder in renal transplant patients. A case report and collective review of cases. Clin. Transplant. 1998; 12: 65-9.
44. Lemy A, Wissing KM, Rorive S etal. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. Am. J. Kidney Dis. 2008; 51: 471-7.
45. Breyer BN, Whitson JM, Freise CE, Meng MV. Prostate cancer screening and treatment in the transplant population: current status and recommendations. J. Urol. 2009; 181: 2018-25; discussion 2025-6.
46. Morton JJ, Howe SF, Lowell JA, Stratta RJ, Taylor RJ. Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen. Br. J. Urol. 1995; 75: 498-501.
47. Woodle ES, Gupta M, Buell JF etal. Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant. Proc. 2005; 37: 958-9.
48. Muruve NA, Shoskes DA. Genitourinary malignancies in solid organ transplant recipients. Transplantation 2005; 80: 709-16.
49. Uzzo RG, Hsu TH, Goldfarb DA etal. Strategies for transplantation of cadaveric kidneys with congenital fusion anomalies. J. Urol. 2001; 165: 761-5.
50. Nie ZL, Li QS, Jin FS etal. [Urological complications in 1223 kidney transplants]. Zhonghua Yi Xue Za Zhi 2009; 89: 1269-71.
51. Streeter EH, Little DM, Cranston DW, Morris PJ. The urological complications of renal transplantation: a series of 1535 patients. BJU Int. 2002; 90: 627-34.
52. Mangus RS, Haag BW. Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation: a metaanalysis. Am. J. Transplant. 2004; 4: 1889-96.
53. Trivedi A, Patel S, Devra A, Rizvi J, Goel R, Modi P. Management of calculi in a donor kidney. Transplant. Proc. 2007; 39: 761-2.
54. Weight C, Shoskes D. Management of urological complications of renal transplantation. AUA Update Ser. 2010; 29: 1-8.
55. Hetet JF, Rigaud J, Leveau E etal. [Therapeutic management of ureteric strictures in renal transplantation]. Prog. Urol. 2005; 15: 472-79; discussion 479-80.
56. Challacombe B, Dasgupta P, Tiptaft R etal. Multimodal management of urolithiasis in renal transplantation. BJU Int. 2005; 96: 385-9.
57. Harper JM, Samuell CT, Hallson PC, Wood SM, Mansell MA. Risk factors for calculus formation in patients with renal transplants. Br. J. Urol. 1994; 74: 147-50.
58. Rhee BK, Bretan PN Jr, Stoller ML. Urolithiasis in renal and combined pancreas/renal transplant recipients. J. Urol. 1999; 161: 1458-62.
59. Tsaur I, Jones J, Melamed RJ, Blaheta RA, Gossmann J, Bentas W. Postoperative voiding dysfunction in older male renal transplant recipients. Transplant. Proc. 2009; 41: 1615-18.
60. Mitsui T, Shimoda N, Morita K etal. Lower urinary tract symptoms and their impact on quality of life after successful renal transplantation. Int. J. Urol. 2009; 16: 388-92.
61. Ehdaie B, Stukenborg GJ, Theodorescu D. Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer. J. Urol. 2009; 182: 1482-7.
62. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am. J. Transplant. 2004; 4: 905-13.
63. Palou J, Angerri O, Segarra J etal. Intravesical bacillus Calmette-Guerin for the treatment of superficial bladder cancer in renal transplant patients. Transplantation 2003; 76: 1514-16.